/b/veterinary-news/posts/103023 Merial has announced the launch of Oncept IL-2, the first veterinary immunotherapeutic product in Europe for the management of cancer in pets. Described by the company as a true breakthrough in the field of veterinary oncology, Oncept IL-2 is an adjuncten-USTelligent Community 10https://www.vetsurgeon.org/b/veterinary-news/posts/103023Fri, 03 Jan 2014 18:43:46 GMT146601cc-3922-4be7-9974-7e1d4e45a66b:1747dcd1-9b1b-4c71-9f28-115171fc6030Laura Atkinson0<p>Interesting. I wonder if there is any information about its use in those cases where owners decide against (or can&#39;t afford) surgery/radiotherapy.</p> <img src="https://www.vetsurgeon.org/aggbug?PostID=103023&AppID=5&AppType=Weblog&ContentType=0" width="1" height="1">